Episode 8

UE LIFESCIENCES

Top facts

UE LifeSciences is a women’s health company focused on preventive oncology. It designs, develops and commercializes medical technology solutions that enable early detection of leading cancers in women.

kuos2eh8w6uxjadmnigw.webp
  • Business Industry:

    Medical Device

  • Number of Employees:

    10-25

  • Business Type:

    B2C & B2B

  • Years in Business:

    10-15

UELS_Team_gcnpib.webp

Our advantage

OUR GOAL

Reach and benefit 10 million women globally. Help improve breast and cervical cancer outcomes for 100,000 women in 5 years.

OUR MISSION

To make early detection of common cancers in women, equitable, inclusive and accessible – with the power of innovation.

915581_276031.webp

Summary

UE LifeSciences is a women’s health company focused on preventive oncology. It designs, develops and commercializes medical technology solutions that enable early detection of leading cancers in women.

AWARDS & RECOGNITIONS

1 - Pennsylvania Department of Health, CURE Grant Award

2 - Global Health Innovation Grant, Pfizer Foundation

3 - Grants 4 Impact, Bayer Cares Foundation

4 - StartHealth, Unitus Seed Fund, India

5 - Digital Health Accelerator, University City Science Center, USA

6 - Helsinn – Lyfebulb Oncology Innovation Award

7 - Aspirin Innovation Award, Bayer Cares Foundation

8 - Inclusive Innovation Award, Anjani Mashelkar Foundation

9 - Arab Health Innov8 Award, Dubai 2019

10 - Lexus Design Award, India 2018

11 - HITLabs World Cup Award, NY 2016

12 - Accenture Healthcare Innovation Challenge Award, SF 2016

13 - IBM Smart Camp for HealthTech India, India 2016

14 - 2014 Marcum Innovator of the Year Award

15 - PACT Enterprise Awards LifeSciences Startup Company

Stay in touch!

Join Our Community

Have a question? We would like to help!

340

Subscribe to our newsletter

successYou have subscribed successfully!
addressaddress

Our Nevada office:401 Ryland St. Suite 200-A, Reno, NV 89502

imdbimdb

Rating8.9 / 10

help-center

Need Help? Click here to visit our Help Center

help-center-arrow

© 2024 Unicorns Inc.All Rights Reserved

Potential investors, prior to subscribing to the securities described here in, should read the offering memorandum related to these securities, and all risk factors and exhibits therein in their entirety. The securities described in the offering memorandum involve a high degree of risk, and returns, including return of capital, are not guaranteed. An offer of our securities is made solely by the offering memorandum, which does not constitute an offer to anyone in any country or state in which such offer or solicitation is not authorized, or to any person to whom it is unlawful to make such an offer or solicitation.

We'd like to use cookies to understand your use of our website. To find out more about cookies and how to change your choices, please go to our .